fda warns against semaglutide consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA crackdown on off-brand Ozempic

The FDA has approved oral semaglutide for two indications: as Rybelsus for the treatment of type 2 diabetes in adults, and as Wegovy pill for chronic weight management in adults

Excess weight puts individuals at higher risk for chronic diseases like type 2 diabetes, heart disease, and certain cancers

The trial data is the strongest evidence available for understanding how these medications perform

Work with your healthcare provider to determine the right dose for your situation

It is unclear whether newer molecules like semaglutide, which are larger and cause more weight loss than some of the earlier iterations, can cross the blood-brain barrier too